The rare disease company

Search for more information about CENTOGENE and its dedicated team of professionals. Find details of our accreditation, commitment to social responsibility and our collaboration partners. Discover the latest news, conferences and events we are attending, plus all our current career opportunities.

  1. About Us

Dedicated to improving the lives of patients every day

CENTOGENE is a worldwide leader in the field of genetic diagnostics for rare hereditary diseases - with the largest test portfolio worldwide. Testing samples from over 110 different countries allows CENTOGENE a unique insight into the epidemiological basis of hereditary disorders, which is crucial for interpreting results and transform it into medical reports.

The company firmly focuses on offering quality molecular genetic diagnostics, underlined by its multiple international accreditations (CAP, CLIA, ISO). Our in-depth medical expertise is supported by the application of cutting-edge technologies, including next generation sequencing, whole genome sequencing (CentoGenome®), whole exome sequencing (CentoXome®) and innovative biomarkers for selected diseases. CENTOGENE has developed a comprehensive mutation database (CentoMD®) that is pivotal to offering high-quality diagnostic reporting and medical interpretation; thoroughly interpreting each patient’s sequence data.

In addition to diagnostic services for individual patients, CENTOGENE is also a pivotal partner for numerous high-profile industrial companies worldwide.

Become part of our team and start your career at CENTOGENE

Join our young and growing company - an international and innovative work environment awaits you in one of the world´s leading companies for rare hereditary diseases diagnostics.


CENTOGENE cares – Our social responsibility

Nowadays, companies realize more than ever the need to take a social responsibility and to give something back the society.

CENTOGENE recognizes its social obligation and is undertaking active and sustainable steps to make the world a better place. As a global leader in the field of clinical genetic diagnostics and interpretation of rare diseases, the health of the people lies in the middle of our hearts.

Read more

Our business locations – Where to find us

CENTOGENE AG is one of the world's leading companies in the field of rare genetic disease diagnostics.

With our broad international network of experienced employees, we are able to offer a wide range of services and support in diverse local languages worldwide.

In collaboration with our partners, we continually develop and test new diagnostic techniques, and are therefore always able to offer you the latest and most effective solutions to your diagnostic challenges.

Rostock Headquarter

Am Strande 7
18055 Rostock

UAE Business Location

Executive office No. 32 Floor 8
Aurora Tower, Dubai Media City
P.O.Box 500717
Dubai, U.A.E 

Austria Business Location

Mariahilfer Str. 36
1070 Vienna

Berlin Business Location

Zimmerstr. 69
10117 Berlin

India Business Location

CENTOGENE India Private Limited
107 Wegman's Business Park, Knowledge Park III,
Surajpur-Kasna Road, Greater NOIDA - 201308,
Uttar Pradesh

USA Business Location

1500 District Avenue
Burlington, MA 01803

Impression of the CentoNew construction site located in the city harbour of Rostock, May 2017
Construction site impressions, January 2017
Video impressions from the construction site, October 2016

Construction site impressions, September 2016
Foundation Stone Ceremony, August 23, 2016
Groundbreaking ceremony, September 30, 2015


Our new headquarter in Rostock will greatly expand our laboratory facilities, with innovative architecture providing a working environment that stimulates productivity, creativity and exchanges of knowledge and ideas. This is crucial to fulfill our mission to play a central role in the new era of personalized medicine, striving to improve healthcare for patients. The impressive new CENTOGENE HQ will incorporate laboratories, offices and a fabulous public area that stretches 4,500m² with great views right across the river Warnow.

We are proud to have been honored with the award from the Federal State Government of Mecklenburg-Vorpommern in the category ‘Company Development’. We are...

Read more

ROSTOCK, GERMANY, June 7, 2018 – CENTOGENE announced today a partnering with the Medical Faculties of the Universities of Greifswald and Rostock for the...

Read more

Rostock, Germany, June 5, 2018 –CENTOGENE announced today the opening of its first U.S. based rare disease laboratory in Cambridge, Massachusetts.  The new...

Read more

CENTOGENE, driving the diagnostic workflows and individualized therapeutic decisions not only in rare diseases but also in oncological setups is proud to host...

Read more

ROSTOCK, GERMANY, June 1, 2018 – CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical...

Read more

Collaboration Builds on Genetic Identification of Patients with Sjögren-Larsson Syndrome (SLS) in a Worldwide Cohort Enabling SLS Patients to Benefit from Novel...

Read more

This year´s European Conference on Rare Diseases and Orphan Products (ECRD 2018 Vienna) gathered over 800 participants from patient organizations, academics,...

Read more

CENTOGENE’s Deep Expertise in Biomarker Identification to Help Guide Clinical Trials

Read more

ROSTOCK, GERMANY, May 9, 2018 – CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and...

Read more